Pienomial
Founded in 2020, Pienomial is redefining how life sciences organizations accelerate and de-risk drug development. Their mission is to empower pharmaceutical, biotech, CROs, and life sciences consulting firms to transform unstructured biomedical data into actionable intelligence, supporting evidence-driven decisions across every phase of the drug lifecycle. At the heart of Pienomial is Knolens, an AI-powered intelligence platform that delivers real-time analysis, intelligent data extraction, and scenario-based modeling across diverse datasets, ensuring accuracy and traceability for smarter decisions in a constantly evolving landscape.
Pienomial
Founded in 2020, Pienomial is redefining how life sciences organizations accelerate and de-risk drug development. Their mission is to empower pharmaceutical, biotech, CROs, and life sciences consulting firms to transform unstructured biomedical data into actionable intelligence, supporting evidence-driven decisions across every phase of the drug lifecycle. At the heart of Pienomial is Knolens, an AI-powered intelligence platform that delivers real-time analysis, intelligent data extraction, and scenario-based modeling across diverse datasets, ensuring accuracy and traceability for smarter decisions in a constantly evolving landscape.